| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
CalciMedica, Inc.
13D/A
Amendment 1
CALC · 38942Q202
|
19.9% |
8/24/2026
Event 8/19/2026
|
|||
| Alafi Capital Company LLC | 19.9% | ||||
| Christopher D. Alafi | 19.9% | ||||
|
CalciMedica, Inc.
13D
CALC · 38942Q202
|
17.1% |
7/10/2026
Event 6/25/2026
|
|||
| Alafi Capital Company LLC | 17.1% | ||||
| Christopher D. Alafi | 17.1% | ||||
|
CalciMedica, Inc.
13G/A
Amendment 1
CALC · 38942Q202
|
11.3% |
8/5/2025
Event 7/22/2025
|
|||
| Alafi Capital Company, LLC | 11.3% | ||||
| Christopher D. Alafi | 11.3% | ||||
|
CalciMedica, Inc.
13G
CALC · 38942Q202
|
9.6% |
4/1/2025
Event 3/25/2025
|
|||
| Alafi Capital Company, LLC | 9.6% | ||||
| Christopher D. Alafi | 9.6% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.